Nicorandil attenuates NF-κB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery

Shock

Volumn 24, Issue 2, 2005, Pages 103-108

  Kawamura, Takae ^a   Kadosaki, Mamoru ^b   Nara, Noriko ^b   Wei, Jicheng ^b   Endo, Shigeatsu ^c   Inada, Katsuya ^c  

^a SENDAI CITY MEDICAL CENTER   (Japan)

^b Memorial Heart Center   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Adhesion molecules; Cardiac anesthesia; Cytokine; Ischemia reperfusion injury; NF KB; Nicorandil

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; CREATINE KINASE MB; CYTOKINE; DIAZEPAM; FENTANYL; GLYCERYL TRINITRATE; HYDROXYZINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NICORANDIL; PETHIDINE; POTASSIUM CHANNEL STIMULATING AGENT; PROPOFOL; SCOPOLAMINE; TRANSFORMING GROWTH FACTOR ALPHA; TROPONIN T;

ANESTHESIA INDUCTION; AORTA OCCLUSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; DRUG MECHANISM; FLOW CYTOMETRY; GRANULOCYTE; HEART INDEX; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HUMAN; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; MONOCYTE; RANDOMIZED CONTROLLED TRIAL; TIME SERIES ANALYSIS;

ANTIGENS, CD18; ANTIHYPERTENSIVE AGENTS; AORTA; BRAIN; CELL ADHESION; CORONARY ARTERY BYPASS; CREATINE KINASE; CYTOKINES; FLOW CYTOMETRY; GRANULOCYTES; HEMODYNAMIC PROCESSES; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MONOCYTES; MUSCLES; MYOCARDIUM; NF-KAPPA B; NICORANDIL; POTASSIUM CHANNELS; REPERFUSION INJURY; TIME FACTORS; TROPONIN T;

EID: 23344454798     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000168874.83401.3f     Document Type: Article

References (36)

1. Lucchesi BR, Werns SW, Fantone JC: The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardial 21:1241-1251, 1989.
2. Dreyer WJ, Michael LH, West MS, Smith CW, Rothlein RD, Anderson DC, Entman ML; Neutrophils accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84:400-411, 1991.
3. Finkel MS, Oddis CV, Jocob TD, Watkins SC, Hauler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389, 1992.
4. Kawamura T, Wakusawa R, Okada K, Inada S: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 40:1016-1021, 1993.
5. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67:1016-1023, 1983.
6. Sterner-Kock A, Braun RK, Schrenzel MD, Hyde DM: Recombinant tumor necrosis factor-α and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro. Immunology 87:454-460, 1996.
7. Steer JH, Kroeger KM, Abraham LJ, Joyce DA: Glucocorticoids suppress tumor necrosis factor-α expression by human monocyte THP-1 cells by suppressing transactivation through adjacent NF-κB and c-Jun-activating iranscription factor-2 binding sites in the promoter. J Biol Chem 275:18432-18440, 2000.
8. Kawamura T, Inada K, Nara N, Wakusawa R, Endo S: Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med 27:545-548, 1999.
9. Pieper GM, Garrett J, Gross GJ: Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 6:225-232, 1992.
10. Yasu T, Ikeda N, Ishizuka N, Matsuda E, Kawakami M, Kuroki M, Imai N, Ueba H, Fukuda S, Schmid-Schonbein GW, Saito M: Nicorandil and leukocyte activation. J Cardiovasc Pharmacol 40:684-692, 2002.
11. + channel opener nicorandil. Eur Heart J 24:1296-1303. 2003.
12. Meldrum DR, Dinarello CA, Shames BD, Cleveland JC Jr, Cain BS, Banerjee A, Meng X, Harken AH: Ischemic preconditioning decreases poslischemic myocardial tumor necrosis factor-α production. Potential ultimate effector mechanism of preconditioning. Circulation 19(Suppl):214-218, 1998.
13. Meldrum DR, Cain BS, Cleveland JC Jr, Meng X, Ayala A, Banerjee A, Harken AH: Adenosine decreases post-ischaemic cardiac TNF-α production: anti-inflammatory implications for preconditioning and transplantation. Immunology 92:472-477, 1997.
14. Knarbanda RK: Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 103:1624-1630, 2001.
15. Wci XM, Heywood GJ, Girolamo ND, Thomas PS: Nicorandil inhibits the release of TNF-α from a lymphocyte cell line and peripheral blood lymphocytes. Int Immunopharmacol 3:1581-1588, 2003.
16. Wolf DL, Ferry JJ, Hearron AE, Froeschke MO, Luderer JR: The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteers. Eur J Clin Pharmacol 44:27-33, 1993.
17. Pyatt DW, Stillman WS, Yang Y, Gross S, Zhang JH, Irons RD: An essential role for NF-kappaB in human CD34(+) bone marrow cell survival. Blood 93:3302-3308, 1999.
18. Murry CE, Jennins RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986.
19. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR: Myocardial protection with preconditioning. Circulation 82:609-619, 1990.
20. Schott RJ, Rohmann S, Braun ER, Schaper W: Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66:1133-1142, 1990.
21. Matsubara T, Minatoguchi S, Matsuo H, Hayakawa K, Segawa T, Matsuno Y, Watanabe S, Arai M, Uno Y, Kawasaki M, Noda T, Takemura G, Nishigaki K, Fujiwara H: Three minute, but not one minute ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol 35:345-351, 2000.
22. Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K, McCabe CH, Braunwald E: Prospective temporal analysis of the onset of preinfarction angina versus outcome an ancillary study in TIM1-9B. Circulation 97:1042-1045, 1998.
23. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, Ueda K: Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis. J Am Coll Cardiol 30:970-975, 1997.
24. 2. Am J Physiol 258:H1847-H1855, 1990.
25. Engler RL, Covell JW: Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res 61:20-28, 1987.
26. Suematsu M, DeLano FA, Poole D, Engler RL, Miyasaka M, Zweifach BW, Schmid-Schonbein GW: Spatial and temporal correlation between leukocyte behaviour and cell injury postischemic rat skeletal muscle micro-circulation. Lab Invest 70:684-695, 1994.
27. Paccaud JP, Shifferli JA, Baggiolini M: NAP-1/IL-8 induces up-regulation of CR1 receptors in human neutrophil leukocytes. Biochem Biophys Res Commun 166:187-192, 1990.
28. 1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokine production during cardiac surgery. Crit Care Med 28:2201-2208, 2000.
29. Schroeder VA, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP: Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation 107:2823-2828, 2003.
30. Kupatt C, Weber C, Wolf DA, Becker BF, Smith TW, Kelly RA: Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: role of NF-κB. J Mol Cell Cardiol 29:2599-2609, 1997.
31. Park SK, Lin HL, Murphy S: Nitric oxide regulates nitric oxide synthase-z gene expression by inhibiting NF-ê binding to DNA. Biochem J 322:609-613, 1997.
32. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK: Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68, 1995.
33. Kaneko T, Saito Y, Hikawa Y, Yasuda K, Makita K: Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischemia in patients undergoing major abdominal surgery. Br J Anaesth 86:332-337, 2001.
34. Blackwell TS, Christman JW: The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3-9, 1997.
35. The IONA Study Group: Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in angina (IONA) randomised trial. Lancet 359:1269-1275, 2002.
36. Kato T, Kamiyama T, Maruyama Y, Tanaka S, Yoshimoto N: Nicorandil, a patent cardioprotective agent, reduces QT dispersion during coronary angioplasty. Am Heart J 141:940-943, 2001.